Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist, which is used in anti-cancer research.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist, which is used in anti-cancer research. |
別名 | UNII-YP9UZR062O, CGP59326, CGP 59326, TRX-13 |
分子量 | 272.73 |
分子式 | C14H13ClN4 |
CAS No. | 173458-56-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP-59326 173458-56-5 UNII-YP9UZR062O CGP59326 CGP 59326 TRX-13 TRX 13 TRX13 Inhibitor inhibitor inhibit